Keywords
children
multibacillar
How to Cite
Abstract
A three-year-old child has received a clinical diagnostic of multibacillary leprosy and has initiated polichemotherapy, developing erythematous infiltrated plaques, with foveolar aspect, disseminated after two months. The child’s mother had received a lepromatous leprosy diagnostic a year ago and in that occasion the child received the BCG vaccine. The clinical reevaluation and the complementary exams from the child confirmed the diagnosis of borderline leprosy with reverse reaction, bacilloscopy 3+, and granular bacilli. This case shows some peculiarities, such as the presence of multibacillary leprosy in this age range, an uncommon fact due to the long period of incubation of the disease, as well as demonstrating that the BCG vaccine has not modified the natural evolution of the disease, as the child presented the disease in an already advanced stage. The authors discuss some aspects of the leprosy in children, e.g. epidemiology, risk factors and diagnosis
resources, and reinforce the importance of an early diagnostic in children who have contact with leprosy carriers, as well as the regular management and incapacity prevention measures.
References
2 Lastória JC, Putinatti MSMA. Utilização de busca ativa de hanseníase: relato de uma experiência de abordagem na detecção de casos novos Hansen. int, 29(1):6-11, 2004.
3 Cortés SL, Rodríguez G. Leprosy in Children: Association between Clinical and Pathological Aspects. Journal of Tropical Pediatrics 2004;50-1:12-15.
4 Saúde.gov.br [página na internet]. Hanseníase. Disponível em: http://portal.saude.gov.br/portal/saude/profissional/area.cfm?id_area=1466
5 Brubaker ML, Meyers WM, Bourland J. Leprosy in Children One Year of Age and Under. International Journal of Leprosy and Other Mycobacterial Diseases 1985;53-4:517-23.
6 Noordeen SK. The epidemiology of leprosy. In: Hastings RC. Leprosy. New York: Longman Group Limited; 1985. p. 15-30.
7 Ura S, Barreto JA. Papel da Biópsia Cutânea no Diagnóstico de Hanseníase. Hansen. int 29(2): 141-144, 2004
8 Opromolla DVA. Diagnóstico. In: Noções de hansenologia. Bauru: Centro de Estudos Dr. Reynaldo Quagliato; 2000. p.59-61.
9 Opromolla DVA. Manifestações clínicas e reações. In: Noções de hansenologia. Bauru: Centro de Estudos Dr. Reynaldo Quagliato; 2000. p.51-58.
10 Sékula SB; Beers SV; Oskam L; Lecco R e cols. A relação entre soroprevalência de anticorpos contra o glicolipídeo fenólico-I entre crianças em idade escolar e endemicidade da hanseníase no Brasil. Revista da Sociedade Brasileira Medicina Tropical 41-2; 81-88, 2008.
11 Nogueira MES, Moreno FRV, Silva EA, Arruda MSP. Imunologia. In: Opromolla DVA. Noções de hansenologia. Bauru: Centro de Estudos Dr. Reynaldo Quagliato; 2000. p.27-42.
12 Talhari S, Neves RG. Manifestações cutâneas e diagnóstico diferencial. In: Hanseníase. Manaus:Gráfica Tropical; 1997. p.5-40.
13 Ura S, Opromolla DVA.Controle. In: Opromolla DVA. Noções de hansenologia. Bauru: Centro de Estudos Dr. Reynaldo Quagliato; 2000. p.109-112.
14 Ura S, Girão RJS, Opromolla DVA, Soares CT, Stump MD. Hanseníase tuberculóide em paciente com AIDS. Hansen. int 29(2): 137-140, 2004
15 Durães SMB, Guedes LS, Cunha MD, Magnanini MMF, Oliveira MLWDR. Estudo epidemiológico de 107 focos familiares de hanseníase no município de Duque de Caxias - Rio de Janeiro, Brasil. An Bras Dermatol. 2010; 85(3): 339-45.
16 Moet FJ, Pahan D, Schuring RP, Oskam L, Richardus JH. Physical distance, genetic relationship, age, and leprosy classification are independent risk factors for leprosy in contacts of patients with leprosy. J Infect Dis. 2006;193:346-53.
This journal is licensed under a Creative Commons Attribution 4.0 International License.
Downloads
